.jpg?format=webp&quality=80&width=3840)
A study conducted by the UK Interstitial Lung Disease Consortium (UKILD) suggests that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may lead to progressive lung damage. The study estimated the prevalence of residual lung abnormalities in people hospitalized with COVID-19 on the basis of risk strata. The study found that residual lung abnormalities were estimated in up to 11% of people discharged after COVID-19–related hospitalization. The study recommends that health services monitor at-risk individuals to elucidate long-term functional implications.
Like
Save
Share